SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 5, 2007
SIGMA-ALDRICH CORPORATION
(Exact Name of Registrant as Specified in its Charter)
| | | | |
| Delaware | | 000-8135 | | 43-1050617 |
(State or Other Jurisdiction
of Incorporation) | | (Commission File Number) | | (IRS Employer
Identification Number) |
3050 Spruce Street
St. Louis, Missouri 63103
(Address of Principal Executive Offices)
Registrant’s telephone number, including area code: (314) 771-5765
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
On July 5, 2007 Sigma-Aldrich issued a press release announcing the promotion of two current senior executives to new responsibilities with the Company. Gerrit van den Dool, 53 will assume expanded duties in the newly created position of Vice President Sales and Dr. David A. Smoller, 44, will become the new President of the Company’s Research Biotech business unit. Shaf Yousaf, previous President of the Company’s Research Biotech business unit has resigned his operational responsibilities effective immediately and will complete transitional responsibilities on August 4, 2007. This press release is furnished as Exhibit 99.1.
| Item 9.01 | Financial Statements and Exhibits. |
The following Exhibits are filed with this Current Report on Form 8-K:
| | |
Exhibit Number | | Description |
| 99.1 | | Press Release issued July 5, 2007 - SIGMA-ALDRICH NAMES NEW SALES & RESEARCH BIOTECH LEADERS. |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | |
| Dated: July 6, 2007 | | | | |
| | |
| | | | SIGMA-ALDRICH CORPORATION |
| | |
| | By: | | /s/ Karen Miller |
| | | | Karen Miller, Corporate Controller |
3
EXHIBIT INDEX
| | |
Exhibit Number | | Description |
| 99.1 | | Press Release issued July 5, 2007 - SIGMA-ALDRICH NAMES NEW SALES & RESEARCH BIOTECH LEADERS. |
4
